RecruitingNot ApplicableNCT07601841

Light Therapy to Improve Sleep in TBI: Sleep-active Biomarkers and Glymphatic Function

Light Therapy to Improve Sleep in Veterans With TBI: Sleep-active Biomarkers and Glymphatic Function


Sponsor

Oregon Health and Science University

Enrollment

300 participants

Start Date

Dec 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a clinical trial designed to examine how improved sleep through morning bright light therapy is improving downstream key physiologic processes related to brain health, i.e., mitochondrial function, systemic inflammation, and glymphatic function. All proposed methodology is already approved in other IRB applications.


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Morning Bright Light Therapy and a medical device called Negative Ion Generator Therapy for people with brain injuries, traumatic, glymphatic system, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 89 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEMorning Bright Light Therapy

Exposure to bright light shortly after waking.

DEVICENegative Ion Generator Therapy

Exposure to negative ions shortly after waking.


Locations(1)

Oregon Health and Science University

Portland, Oregon, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07601841


Related Trials